Hillan Kenneth J. has filed 9 insider transactions across 3 companies since February 2023.
Most recent transaction: a grant/award of 25000 shares of SANGAMO THERAPEUTICS, INC ($SGMO) on June 12, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Hillan Kenneth J. | Not found | A | Common Stock | 25000 | $0.00 | 99,600.0000 | 224,710,019 | 33.51% | 0.01% |
| June 12, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Hillan Kenneth J. | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 224,710,019 | 9999.99% | 0.02% |
| June 4, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Hillan Kenneth J. | Not found | A | Common Stock | 25000 | $0.00 | 74,600.0000 | 0 | 50.40% | 0.00% |
| June 4, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Hillan Kenneth J. | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 7, 2023 | Zymeworks Inc. | $ZYME | Hillan Kenneth J. | Not found | A | Stock Option (Right to Buy) | 37000 | $0.00 | 37,000.0000 | 65,249,184 | 9999.99% | 0.06% |
| June 5, 2023 | Chrome Holding Co. | $MEHCQ | Hillan Kenneth J. | Chief Therapeutics Officer | A | Class A Common Stock | 44381 | $0.00 | 237,223.0000 | 22,575,219 | 23.01% | 0.20% |
| June 5, 2023 | Chrome Holding Co. | $MEHCQ | Hillan Kenneth J. | Chief Therapeutics Officer | F | Class A Common Stock | 15347 | $2.08 | 221,876.0000 | 22,575,219 | 6.47% | 0.07% |
| May 20, 2023 | Chrome Holding Co. | $MEHCQ | Hillan Kenneth J. | Chief Therapeutics Officer | F | Class A Common Stock | 4628 | $1.94 | 192,842.0000 | 22,575,219 | 2.34% | 0.02% |
| Feb. 20, 2023 | Chrome Holding Co. | $MEHCQ | Hillan Kenneth J. | Chief Therapeutics Officer | F | Class A Common Stock | 5457 | $2.87 | 191,705.0000 | 0 | 2.77% | 0.00% |